Luyan Pharma Co Ltd (002788) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.036x

Based on the latest financial reports, Luyan Pharma Co Ltd (002788) has a cash flow conversion efficiency ratio of 0.036x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥118.98 Million ≈ $17.41 Million USD) by net assets (CN¥3.26 Billion ≈ $477.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 002788 company net worth for the company's overall valuation and market capitalisation.

Luyan Pharma Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2025)

This chart illustrates how Luyan Pharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Luyan Pharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Luyan Pharma Co Ltd ranked by their cash flow conversion efficiency. Explore Luyan Pharma Co Ltd cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Western Asset Diversified Income Fund NYSE:WDI	0.014x
Anhui Huaheng Biotechnology Co. Ltd. A SHG:688639	-0.004x
Aris Water Solutions Inc NYSE:ARIS	0.093x
Medigen Vaccine Biologics TWO:6547	-0.016x
T'way Air Co Ltd KO:091810	0.196x
Cubic Sensor and Instrument Co Ltd SHG:688665	0.039x
Shenzhen Prince New Materials Co Ltd SHE:002735	0.021x
Corporación Actinver S. A. B. de C. V MX:ACTINVRB	0.039x

Annual Cash Flow Conversion Efficiency for Luyan Pharma Co Ltd (2011–2025)

The table below shows the annual cash flow conversion efficiency of Luyan Pharma Co Ltd from 2011 to 2025. View Luyan Pharma Co Ltd stock quote for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥3.32 Billion ≈ $486.42 Million	CN¥688.40 Million ≈ $100.73 Million	0.207x	+14.47%
2024-12-31	CN¥3.19 Billion ≈ $467.08 Million	CN¥577.48 Million ≈ $84.50 Million	0.181x	-58.86%
2023-12-31	CN¥2.98 Billion ≈ $435.62 Million	CN¥1.31 Billion ≈ $191.57 Million	0.440x	+428.54%
2022-12-31	CN¥2.79 Billion ≈ $408.36 Million	CN¥232.19 Million ≈ $33.98 Million	0.083x	+157.26%
2021-12-31	CN¥2.56 Billion ≈ $374.63 Million	CN¥-372.02 Million ≈ $-54.44 Million	-0.145x	-552.79%
2020-12-31	CN¥2.41 Billion ≈ $352.11 Million	CN¥77.22 Million ≈ $11.30 Million	0.032x	+109.63%
2019-12-31	CN¥1.89 Billion ≈ $276.28 Million	CN¥-629.14 Million ≈ $-92.06 Million	-0.333x	-534.66%
2018-12-31	CN¥1.65 Billion ≈ $241.97 Million	CN¥126.77 Million ≈ $18.55 Million	0.077x	+126.85%
2017-12-31	CN¥1.57 Billion ≈ $229.21 Million	CN¥-447.16 Million ≈ $-65.43 Million	-0.285x	-207.31%
2016-12-31	CN¥1.38 Billion ≈ $201.67 Million	CN¥-128.03 Million ≈ $-18.73 Million	-0.093x	-31699.60%
2015-12-31	CN¥746.00 Million ≈ $109.16 Million	CN¥219.31K ≈ $32.09K	0.000x	-99.89%
2014-12-31	CN¥649.30 Million ≈ $95.01 Million	CN¥177.89 Million ≈ $26.03 Million	0.274x	+299.88%
2013-12-31	CN¥557.87 Million ≈ $81.63 Million	CN¥-76.47 Million ≈ $-11.19 Million	-0.137x	-86.46%
2012-12-31	CN¥448.15 Million ≈ $65.58 Million	CN¥-32.94 Million ≈ $-4.82 Million	-0.074x	-193.16%
2011-12-31	CN¥354.91 Million ≈ $51.93 Million	CN¥28.01 Million ≈ $4.10 Million	0.079x	--

About Luyan Pharma Co Ltd

SHE:002788 China Pharmaceutical Retailers

Market Cap

$656.07 Million

CN¥4.48 Billion CNY

Market Cap Rank

#11025 Global

#3065 in China

Share Price

CN¥11.54

Change (1 day)

+5.29%

52-Week Range

CN¥7.99 - CN¥27.49

All Time High

CN¥22328.40